INS and diabetes mellitus: Diabetes technologies such as continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) can reduce overall episodes of hypoglycaemia [13,14], improve glycaemic control and decrease the risk of microvascular complications [15].